Biocon Limited
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-08
Analyst
Barclays
Equibles does not estimate personal net worth.
Imtia Shafarin is recorded as Analyst at Barclays. Imtia Shafarin has spoken on 1 earnings call across 1 company, most recently for Biocon Limited on May 8, 2026. The companies whose calls Imtia Shafarin spoke on are classified in the Healthcare sector.
“A couple of questions for me with regards to your US dollar bonds. Would you be able to provide some color on your hedging policy? I know you have benefits, I mean, currency benefits, but any specific hedging policy you have on the US dollar bonds?”
Barclays
Analyst
Transcript header (unverified)
Biocon Limited
Biotechnology · Healthcare
Biocon Limited Q4 FY26 Earnings Call
Biocon Limited